Risk and risk factors of hepatocellular carcinoma (HCC) in Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis treated with entecavir (ETV) or tenofovir (TDF)

Autore

Papatheodoridis, G. V.; Dalekos, G. N.; Yurdaydin, C.; Goulis, I.; Arends, P.; Buti, M.; Sypsa, V.; Manolakopoulos, S.; Mangia, G.; Gatselis, N.; Keskin, O.; Savvidou, S.; Hansen, B. E.; Papaioannou, C.; Galanis, K.; Idilman, R.; Colombo, M.; Esteban, R.; Janssen, H. L.; Lampertico, P.

Data

2013

Soggetto

Gastroenterology & Hepatology

Mostra tutti i dati dell'item

URI

http://hdl.handle.net/11615/31948

Collections

• Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ. [19743]